Injectable oxidized hyaluronic acid/adipic acid dihydrazide hydrogel for nucleus pulposus regeneration

Add time:08/01/2019    Source:sciencedirect.com

Injectable hydrogel allows irregular surgical defects to be completely filled, lessens the risk of implant migration, and minimizes surgical defects due to the solution–gel state transformation. Here, we first propose a method for preparing oxidized hyaluronic acid/adipic acid dihydrazide (oxi-HA/ADH) injectable hydrogel by chemical cross-linking under physiological conditions. Fourier transform infrared spectrometry and trinitrobenzene sulfonate assay were used to confirm the oxidation of hyaluronic acid. Rheological properties were measured to evaluate the working ability of the hydrogel for further clinical application. The oxi-HA/ADH in situ forming hydrogel can transform from liquid form into a gel-like matrix within 3–8 min, depending on the operational temperature. Furthermore, hydrogel degradation and cell assessment is also a concern for clinical application. Injectable oxi-HA/ADH8 hydrogel can maintain its gel-like state for at least 5 weeks with a degradation percentage of 40%. Importantly, oxi-HA/ADH8 hydrogel can assist in nucleus pulposus cell synthesis of type II collagen and aggrecan mRNA gene expression according to the results of real-time PCR analysis, and shows good biocompatibility based on cell viability and cytotoxicity assays. Based on the results of the current study, oxi-HA/ADH hydrogel may possess several advantages for future application in nucleus pulposus regeneration.

We also recommend Trading Suppliers and Manufacturers of Adipic dihydrazide (cas 1071-93-8). Pls Click Website Link as below: cas 1071-93-8 suppliers

Prev:Mechanical properties of films of latexes based on copolymers BA/MMA/DAAM and BA/MMA/VEOVA-10/DAAM and the corresponding self-crosslinked copolymers using the adipic acid dihydrazide as crosslinking agent
Next:Computational and electrochemical investigation for corrosion inhibition of nickel in molar sulfuric acid by dihydrazide derivatives. Part II)